Louis Gleckel - Jun 16, 2023 Form 4/A - Amendment Insider Report for ProPhase Labs, Inc. (PRPH)

Role
Director
Signature
/s/ Louis Gleckel MD
Stock symbol
PRPH
Transactions as of
Jun 16, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/22/2023, 08:17 PM
Date Of Original Report
Jun 21, 2023
Previous filing
Jul 5, 2022
Next filing
Jun 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Award $0 +40K $0.00 40K Jun 16, 2023 Common Stock 40K $7.31 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the "Option"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023.
F2 This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023.